GI motility refers to the progression of food, fluids and waste through the digestive tract. Motility problems include acid reflux, chronic constipation and incontinence.
Cedars-Sinai's GI Motility Program is unique among motility centers because it treats almost all GI motility problems. We focus on the diagnosis and treatment of these digestive tract problems. Our program offers the most advanced diagnosis and treatment methods and is recognized throughout the world for our latest research discoveries, which are already being used to help patients.
IBS and Food Poisoning
A study has revealed a link between irritable bowel syndrome (IBS) and food poisoning and shows that military personnel are at a much higher risk for the disorder than the rest of the population. IBS afflicts an estimated 30 million people. Studies conducted at Cedars-Sinai demonstrate that food poisoning triggers IBS through a cascade of neurotoxic events that affects the small intestine and ultimately leads to bacterial buildup.Read Full Story
Cedars-Sinai researchers have determined that two prevalent drug therapies - rifaximin and lubiprostone - offer some of the best options for treating IBS, a widespread disorder that affects one in five Americans. Patients living with IBS often experience abdominal pain, excess gas and visible abdominal distension. Many drug therapies cause troubling side effects of their own, including nausea, insomnia, palpitations and decreased appetite.Read Full Story